Thus, the drug may have acted on the few HER2 molecules present, and in the case of the cell line UNESP-MM1, the action could be related to binding to EGFR [16,51], this ability of lapatinib to inhibit EGFR phosphorylation has already been described in feline mammary cancer cells [22]. The gene discussed is EGFR; the disease is breast cancer.